International Journal of Radiation Oncology*Biology*Physics
Volume 102, Issue 1, 1 September 2018, Pages 1-4
FeatureTwo Sides of the Same Coin: Head and Neck Cancer Treatment De-Intensification and Intensification with Induction Chemotherapy
References (16)
- et al.
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: A single-arm, phase 2 study
Lancet Oncol
(2017) - et al.
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial
Ann Oncol
(2017) - et al.
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer
Ann Oncol
(2014) - et al.
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial
Lancet Oncol
(2013) - et al.
HPV-associated head and neck cancer: A virus-related cancer epidemic
Lancet Oncol
(2010) - et al.
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase 3, multicentre, randomised controlled trial
Lancet Oncol
(2016) - et al.
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Radiother Oncol
(2009) - et al.
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site
Radiother Oncol
(2011)
There are more references available in the full text version of this article.
Cited by (0)
Conflict of interest: none.
© 2019 Published by Elsevier Inc.